Notices

MEDIUS Holdings Co., Ltd., Ltd. (Head office: Chiyoda-ku, Tokyo; President and CEO Medius Holdings Co., Ltd. Yasuhiko Ikeya; hereinafter referred to as MEDIUS HD") will begin a demonstration experiment to improve the efficiency of medical equipment delivery in collaboration with MEDIUS Mediris Logistics Co., Ltd., Ltd. (Head office: Chiyoda-ku, Tokyo; President and CEO Medius Holdings Co., Ltd.: Tatsuichi Sakai; hereinafter referred to as "Mediris Logi"), a subsidiary of Medias Holdings, and Sunmedix Co., Ltd. (Head office: Chuo-ku, Tokyo; President and CEO Medius Holdings Co., Ltd.: Satoshi Morikawa; hereinafter referred to as "Sunmedix"), a medical equipment wholesaler, with the aim of improving the efficiency of medical equipment delivery and building a sustainable logistics system.

For many years, MEDIUS Group has supported medical facilities by supplying over one million products, from medical consumables to cutting-edge medical equipment. Medilis Logi is a logistics company established in March 2025 that brings together the know-how cultivated by our group, aiming to achieve safe and prompt medical logistics, improve logistics efficiency, and reduce environmental impact.

In recent years, structural issues have become apparent in the logistics sector, such as rising labor and fuel costs, and a decline in transportation capacity due to the impact of the Work Style Reform Act. In the medical device sector, there is a strong demand for "safety, responsiveness, and stable supply," and the increased logistics risks and rising costs are having a direct impact on the field.
Furthermore, traditionally, deliveries were made individually by each manufacturer and wholesaler, resulting in long-standing issues such as low loading rates, overlapping delivery routes, and inefficient return logistics.

This demonstration experiment is the first step in efforts to resolve these industry-wide issues, disperse and absorb logistics risks, reduce costs, and build sustainable medical device logistics. By combining MEDIUS Group's extensive distribution network with the know-how of Sunmedix and Mediris Logi, the project will verify the effects of joint delivery, such as improved loading rates, reduced vehicle deployment, and reduced environmental impact.

[Outline of the demonstration experiment]
Target area: Kanto area, centered on Tokyo, Tochigi, and Gunma
Target items: Medical equipment, medical consumables, etc.
Verification period: January to June 2026 (planned)
Verification details: Improved loading rate through joint flights, reduced number of vehicles dispatched, reduced environmental impact, etc.
*Based on the results and issues obtained from the experiment, we will consider expanding the target area and routes in the future.

MEDIUS Group will continue to contribute to the development of regional medical care by providing innovative and sustainable logistics solutions for medical facilities and the patients they serve.

[Participating companies]
Sunmedics Co., Ltd. (1-8-11 Harumi, Chuo-ku, Tokyo)
https://www.sunmedix.co.jp/
MEDIUS Holdings Co., Ltd. (1-2-2 Yurakucho, Chiyoda-ku, Tokyo)
Mediris Logistics Co., Ltd. (1-2-2 Yurakucho, Chiyoda-ku, Tokyo)


About SunMedics Co., Ltd.
As a general medical equipment trading company with bases mainly in the Kanto region, we have expanded the scope of our services based on the expertise we have cultivated in surgery-related operations while meeting the diverse needs of medical institutions. We are promoting business improvement and logistics system development in line with changes in the medical system, and are venturing into new fields such as regenerative medicine products. We aim to be a trusted company that is close to the medical field by strengthening our human resource development through the use of ICT and hybrid education. We will continue to innovate in order to "achieve better health and medical care."